Aramark (ARMK) Reports Q3 Earnings: What Key Metrics Have to Say

Aramark (ARMK) reported Q3 2025 revenue of $4.63 billion, a 5.7% year-over-year increase, which slightly missed the $4.66 billion consensus estimate. Diluted EPS reached $0.40, up from $0.31 year-over-year and meeting expectations. While the company's FSS International revenue exceeded forecasts, its FSS United States revenue and operating income across both segments fell short of analyst projections. ARMK shares have outperformed the S&P 500 over the past month, and the stock currently carries a Zacks Rank #2 (Buy).

Analysis

Aramark's third-quarter results present a mixed operational picture, characterized by solid year-over-year growth but a failure to meet specific market expectations. The company reported a 5.7% increase in revenue to $4.63 billion, which nonetheless represented a -0.77% miss against the Zacks Consensus Estimate of $4.66 billion. On the bottom line, EPS grew substantially to $0.40 from $0.31 in the prior-year quarter, meeting analyst forecasts precisely. A deeper look at the segments reveals a significant divergence in performance. The FSS International segment was a key top-line driver, with revenue of $1.38 billion growing 12% and beating estimates. However, this strength was offset by underperformance in the larger FSS United States segment, where revenue of $3.25 billion missed its $3.36 billion projection. More critically, operating income across both the US and International segments fell short of analyst estimates, with the FSS International unit's operating income of $49.06 million missing its $67.95 million target substantially, indicating potential margin pressure despite strong sales.

Key Decisions for Investors

• Investors should weigh the strong year-over-year EPS growth against the underlying weakness in operating profitability, as both FSS US and International segments missed operating income forecasts, suggesting margin pressures.
• The revenue underperformance in the FSS United States segment, the company's largest division, warrants close scrutiny as it could signal a slowdown or competitive pressure in its core market.
• Given the mixed operational results against a backdrop of recent stock outperformance and a Zacks #2 (Buy) rank, a hold-and-monitor approach may be prudent, pending further clarity on margin stabilization and US segment trends.